Recruitment for Medical & Paramedical staff at PESIMSR - Multiple vacancies

PESIMSR is a well established Medical College with an attached 750 Bed Hospital containing state-of-the-art facilities providing wonderful work experience and training opportunities.  India, the world’s biggest democracy, ranks eleventh in the world in terms of the size of its economy with the GNP equivalent to US$471 billion, but ranks 162nd in the world in terms ofGNP per capita (US$460).  India is now going through an epidemiological transition, where infectious diseases are receding as causes of adult morbidity and mortality, whereas non-infectious diseases are assuming menacing proportions. The risk factors associated with changing lifestyle have increased the mortality rate because of coronary heart diseases, diabetes, hypertension and neurological disorders.

Require Junior Research Fellow in Bodoland University | walk in

Bodoland University was established by Bodoland University Act 2009, passed in the Assam legislative Assembly. The present Bodoland University is an up-gradation of the Kokrajhar campus of Gauhati University to a full fledged state University as per the provision of the Act. The setting-up of the new university comes as a fulfillment of the dreams of the people of entire lower Assam, irrespective of caste, creed or economic status. The new university would cater to the educational need of the people, not only of the Bodoland area but also the adjoining states and nations like Bhutan, Nepal and Bangladesh.

Applications are invited for a JRF/Project Fellow position to work on a DST (SERB), Govt, of India sponsored research project with the following details.

Post : JRF

Vacancy for Pharmacist under Urban Health Society at VMC

A memorable advance was made in the development of local self Govt. in Baroda State in the year 1892, when Sudharai Nibandh Municipal Act was passed by his highness Late Shri Maharaja Sayajirao Gaekwad. It recoginsed for the first time the elective principal in Baroda Municipal Govt. Under this Act, the city was devided into 22 wards, each to elect one member to the Municipal Baroda. Besides the large number of elected members, there were eight ex-officio members, The Sudharai Kamdar, The municipal commissioner being the ex-officio president of the municipality. The whole cost of municipal administration was borne by the Baroda State Govt.

Post : Pharmacist

Job for Project Management - Client of Nurture Consultancy | 05 posts

A well reputed Pharma manufacturing company.

Post: Project Management ( 5-6 posts)

Simplification of complex proton NMR spectrum

Q.3. (b) Simplification of complex proton NMR spectrum

Spin-spin splitting and factors influencing coupling constant

Q.3.(a)Spin-spin splitting and factors influencing coupling constant

Astellas Pharma Inc. and Pfizer Inc. announced the US Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) to update the US product labeling for Xtandi (enzalutamide) capsules to include new clinical data versus bicalutamide from the TERRAIN study. The data demonstrate improvement in radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (CRPC) who were treated with enzalutamide compared to patients who were treated with bicalutamide.

 Portola Pharmaceuticals Inc.  announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval to market betrixaban for extended-duration prophylaxis of venous thromboembolism (VTE) in acute medically ill patients with risk factors for VTE. Betrixaban, an FDA Fast Track-designated investigational drug, is an oral, once-daily Factor Xa inhibitor anticoagulant.

Oasmia Pharmaceutical, a company develops a new generation of drugs within human and veterinary oncology, and Karo Pharma have entered into an agreement under which Oasmia to acquire Karo Pharma's cancer project KB9520, which has shown promising results in pre-clinical models for a number of different types of cancer.

Abeona Therapeutics Inc. Announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for ABO-102, a single intravenous injection of AAV gene therapy for subjects with MPS IIIA (Sanfilippo syndrome type A), a rare autosomal recessive disease affecting every cell and organ in the body causing neurocognitive decline, speech loss, loss of mobility, and premature death in children.